These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22890208)

  • 21. Evaluation of romiplostim for the treatment of secondary failure of platelet recovery among allogeneic hematopoietic stem cell transplant patients.
    Hartranft ME; Clemmons AB; DeRemer DL; Kota V
    J Oncol Pharm Pract; 2017 Jan; 23(1):10-17. PubMed ID: 26471738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Romiplostim Treatment of Chemotherapy-Induced Thrombocytopenia.
    Soff GA; Miao Y; Bendheim G; Batista J; Mones JV; Parameswaran R; Wilkins CR; Devlin SM; Abou-Alfa GK; Cercek A; Kemeny NE; Sarasohn DM; Mantha S
    J Clin Oncol; 2019 Nov; 37(31):2892-2898. PubMed ID: 31545663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modeling and simulation support eltrombopag dosing in thrombocytopenic patients with chronic HCV infection.
    Zhang J; Thapar M; Farrell C; Wire MB
    Pharm Res; 2015 Jun; 32(6):2015-28. PubMed ID: 25534682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pegylated interferon-alpha2b plus ribavirin: an efficacious and well-tolerated treatment regimen for patients with hepatitis C virus related histologically proven cirrhosis.
    Roffi L; Colloredo G; Pioltelli P; Bellati G; Pozzpi M; Parravicini P; Bellia V; Del Poggio P; Fornaciari G; Ceriani R; Ramella G; Corradi C; Rossini A; Bruno S;
    Antivir Ther; 2008; 13(5):663-73. PubMed ID: 18771050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of thrombocytopenia on treatment tolerability and outcome in patients with chronic HCV infection and advanced hepatic fibrosis.
    Maan R; van der Meer AJ; Hansen BE; Feld JJ; Wedemeyer H; Dufour JF; Zangneh HF; Lammert F; Manns MP; Zeuzem S; Janssen HL; de Knegt RJ; Veldt BJ
    J Hepatol; 2014 Sep; 61(3):482-91. PubMed ID: 24780302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interference of hepatitis B virus dual infection in platelet count recovery in chronic hepatitis C patients with curative antiviral therapy.
    Huang CF; Yeh ML; Huang CI; Lin ZY; Chen SC; Dai CY; Huang JF; Chuang WL; Yu ML
    J Gastroenterol Hepatol; 2018 May; 33(5):1108-1114. PubMed ID: 29023927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hematologic indices improve with eradication of HCV in patients with cirrhosis and predict decompensation.
    Karagozian R; Grace ND; Qamar AA
    Acta Gastroenterol Belg; 2014 Dec; 77(4):425-32. PubMed ID: 25682633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Romiplostim in patients with refractory aplastic anaemia previously treated with immunosuppressive therapy: a dose-finding and long-term treatment phase 2 trial.
    Lee JW; Lee SE; Jung CW; Park S; Keta H; Park SK; Kim JA; Oh IH; Jang JH
    Lancet Haematol; 2019 Nov; 6(11):e562-e572. PubMed ID: 31474546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune thrombocytopenia and anticoagulation: the role of romiplostim in the early treatment.
    Cantoni N; Heizmann M; Bargetzi M
    Br J Haematol; 2012 Jun; 157(5):639-41. PubMed ID: 22329466
    [No Abstract]   [Full Text] [Related]  

  • 30. Romiplostim in chronic liver disease with severe thrombocytopenia undergoing an elective invasive procedure.
    Castellote J; Girbau A; Arajol C; Xiol X
    Rev Esp Enferm Dig; 2011 Oct; 103(10):556. PubMed ID: 22054278
    [No Abstract]   [Full Text] [Related]  

  • 31. Romiplostim treatment allows for platelet transfusion-free liver transplantation in pediatric thrombocytopenic patient with primary sclerosing cholangitis.
    Minowa K; Arai K; Kasahara M; Sakamoto S; Shimizu H; Nakano N; Ito R; Obayashi N; Nakazawa A; Ishiguro A
    Pediatr Transplant; 2014 Sep; 18(6):E212-5. PubMed ID: 25041553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical efficacy and safety of the combination therapy of peginterferon alpha and ribavirin in cirrhotic patients with HCV infection].
    Cheong HR; Woo HY; Heo J; Yoon KT; Kim DU; Kim GH; Kang DH; Song GA; Cho M
    Korean J Hepatol; 2010 Mar; 16(1):38-48. PubMed ID: 20375641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Romiplostim in chronic immune thrombocytopenic purpura.
    Cersosimo RJ
    Clin Ther; 2009 Sep; 31(9):1887-907. PubMed ID: 19843480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
    Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
    J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Romiplostim for chronic lymphocytic leukemia-associated immune thrombocytopenia.
    D'Arena G; Cascavilla N
    Leuk Lymphoma; 2011 Apr; 52(4):701-4. PubMed ID: 21171868
    [No Abstract]   [Full Text] [Related]  

  • 36. Romiplostim in the management of thrombocytopenia in a patient with autoimmune hepatitis.
    Gangireddy VG; Coleman TA; Nabh A; Sridhar S
    Dig Dis Sci; 2012 Sep; 57(9):2466-72. PubMed ID: 22828806
    [No Abstract]   [Full Text] [Related]  

  • 37. A novel approach to the evaluation of bleeding-related episodes in patients with chronic immune thrombocytopenia.
    Weitz I; Sanz MA; Henry D; Schipperus M; Godeau B; Northridge K; Gleeson M; Danese M; Deuson R
    Curr Med Res Opin; 2012 May; 28(5):789-96. PubMed ID: 22494019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement of platelets after SVR among patients with chronic HCV infection and advanced hepatic fibrosis.
    van der Meer AJ; Maan R; Veldt BJ; Feld JJ; Wedemeyer H; Dufour JF; Lammert F; Duarte-Rojo A; Manns MP; Zeuzem S; Hofmann WP; de Knegt RJ; Hansen BE; Janssen HL
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1168-76. PubMed ID: 26647353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The role and possibilities of natural interferon treatment in chronic hepatitis C: experience with natural interferon treatment for patients barred from combined antiviral therapy because of the STOP rule].
    Horváth G; Tolvaj G; Halász T; Stotz G
    Orv Hetil; 2007 Aug; 148(33):1545-50. PubMed ID: 17686672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythematous rash following romiplostim administration in a patient with autoimmune lymphoproliferative syndrome.
    Biondo L; Bodge M; Paul SR
    Ann Pharmacother; 2013 Jan; 47(1):e7. PubMed ID: 23300150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.